Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831102 · ClinicalTrials.gov registry record
Adiponectin and Ethnic Differences in Insulin Resistance
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 43
- Enrollment target
NCT01831102: Completed study, sponsored by University of Colorado, Denver.
NCT01831102 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01831102 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The purpose of this protocol is to measure and compare levels of the circulating protein adiponectin and adiponectin's association with insulin sensitivity in Mexican Americans and non-Latino white subjects. The investigators also aimed to examine associations between nutritional factors and adiponectin levels.
Interventions
- OTHER none- observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-08 |
What the finished NCT01831102 record still lists
NCT01831102 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which none- observational study is the first listed.
NCT01831102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01831102 about?
NCT01831102 is a clinical study titled "Adiponectin and Ethnic Differences in Insulin Resistance". The purpose of this protocol is to measure and compare levels of the circulating protein adiponectin and adiponectin's association with insulin sensitivity in Mexican Americans and non-Latino white subjects. The investigators also aimed to examine associations between nutritional factors and adipone...
What is the current status of trial NCT01831102?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2011-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01831102?
The interventions under investigation include: none- observational study (OTHER).
Who is sponsoring clinical trial NCT01831102?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia